| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Viking Therapeutics, Inc. (VKTX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. VKTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.57M | $85.66M | -148,517 | |
| COO | 422.8K | $14.08M | -18,217 | |
| CFO | 212.2K | $7.07M | -21,217 | |
| Dir | 148.0K | $4.93M | - | |
| Dir | 51.1K | $1.70M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 25, 2024 | Singleton J Matthew75 | Director | Sale+OE | 16,000 | $79.50 | $1,272,000.00 | -62.7% | -55.2% | -55.9% | |
| Oct 25, 2024 | Rouan Sarah Kathryn49 | Director | Sale+OE | 11,000 | $80.89 | $889,790.00 | -100% | -55.2% | -55.9% | |
| Sep 20, 2024 | Singleton J Matthew75 | Director | Sale+OE | 10,300 | $69.50 | $715,850.00 | -52.0% | -41.1% | -64.0% | |
| Sep 20, 2024 | Lian Brian52 | President &CEO | Sale+OE | 216,130 | $70.83 | $15,308,552.90 | -3.0% | -41.1% | -64.0% | |
| Aug 21, 2024 | Lian Brian52 | President &CEO | Sale+OE | 1,000 | $69.90 | $69,900.00 | - | -20.5% | -60.4% | |
| Aug 21, 2024 | Singleton J Matthew75 | Director | Sale+OE | 5,700 | $69.72 | $397,430.22 | -37.5% | -20.5% | -60.4% | |
| Aug 19, 2024 | Singleton J Matthew75 | Director | Sale+OE | 16,000 | $62.22 | $995,453.24 | -14.8% | -26.3% | -63.4% | |
| Aug 19, 2024 | Lian Brian52 | President &CEO | Sale+OE | 112,870 | $65.80 | $7,426,507.68 | -1.6% | -26.3% | -63.4% | |
| Aug 14, 2024 | Singleton J Matthew75 | Director | Sale+OE | 20,786 | $57.53 | $1,195,736.21 | -52.0% | +4.1% | -30.9% | |
| Jul 30, 2024 | Zante Greg53 | Chief Financial Officer | Sell | 16,136 | $57.15 | $922,212.06 | -2.8% | +31.8% | -40.4% |